Brice Epry News Today

TISSIUM Selected for French Tech 120 Program This is the second year TISSIUM has been included in the program for late-stage startups. TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has been named a French Tech 120 company for the 2021 program. French Tech 120 is a growth-stage program by La French Tech, built to provide government-backed support for the 120 fastest growing companies in France. This is the sec...